"A doctor should be a clown at heart, a scientist at brain and a mother at conscience." Abhijit Naskar - this is not just a name - it's an idea - an idea of self-realization - an idea of a healthy humanity - an idea of one humanity. And that idea rises through this book once again to extend the flow of practical philosophy of life to all practitioners of medicine. This is a humanitarian guidebook of the true philosophy, ethics and purpose of medical practice for all doctors and would-be doctors to understand themselves and their patients better. Naskar, the humanitarian neuroscientist lends a hand to the bold and life-saving individuals known as doctors in their practice of medicine, so that they could, in the truest sense of the term "save lives" and not just treat sick bodies.

For more than 50 years, low-cost antimalarial drugs silently saved millions of lives and cured billions of debilitating infections. Today, however, these drugs no longer work against the deadliest form of malaria that exists throughout the world. Malaria deaths in sub-Saharan Africaâ€"currently just over one million per yearâ€"are rising because of increased resistance to the old, inexpensive drugs. Although effective new drugs called "artemisinins" are available, they are unaffordable for the majority of the affected population, even at a cost of one dollar per course. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance examines the history of malaria treatments, provides an overview of the current drug crisis, and offers recommendations on maximizing access to and effectiveness of antimalarial drugs. The book finds that most people in endemic countries will not have access to currently effective combination treatments, which should include an artemisinin, without financing from the global community. Without funding for effective treatment, malaria mortality could double over the next 10 to 20 years and transmission will intensify.

The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.

The moving memoir of one of the most senior-ranking combat physicians to have served on the battlefields of the second Iraq war.

"Wonderful... Physicans would do well to learn this most important lesson about caring for patients." —The New York Times Book Review Over the years that Victoria Sweet has been a physician, “healthcare” has replaced medicine, “providers” look at their laptops more than at their patients, and costs keep soaring, all in the ruthless pursuit of efficiency. Yet the remedy that economists and policy makers continue to miss is also miraculously simple. Good medicine takes more than amazing technology; it takes time—time to respond to bodies as well as data, time to arrive at the right diagnosis and the right treatment. Sweet knows this because she has learned and lived it over the course of her remarkable career. Here she relates unforgettable stories of the teachers, doctors, nurses, and patients through whom she discovered the practice of Slow Medicine, in which she has been both pioneer and inspiration. Medicine, she helps us to see, is a craft and an art as well as a science. It is relational, personal, even spiritual. To do it well requires a hard-won wisdom that no algorithm can replace—that brings together “fast” and “slow” in a truly effective, efficient, sustainable, and humane way of healing.

This hard-hitting expose does for prescription drugs what "Silent Spring" did for pesticides, revealing the hidden dangers of the most commonly prescribed medications--and what the consumer can do to minimize the risks of serious side effects.

Today we live longer, healthier lives than ever before in history—a transformation due almost entirely to tremendous advances in medicine. This change is so profound, with many major illnesses nearly wiped out, that its hard now to imagine what the world was like in 1851, when the New York Times began publishing. Treatments for depression, blood pressure, heart disease, ulcers, and diabetes came later; antibiotics were nonexistent, viruses unheard of, and no one realized yet that DNA carried blueprints for life or the importance of stem cells. Edited by award-winning writer Gina Kolata, this eye-opening collection of 150 articles from the New York Times archive charts the developing scientific insights and breakthroughs into diagnosing and treating conditions like typhoid, tuberculosis, cancer, diabetes, Alzheimers, and AIDS, and chronicles the struggles to treat mental illness and the enormous success of vaccines. It also reveals medical mistakes, lapses in ethics, and wrong paths taken in hopes of curing disease. Every illness, every landmark has a tale, and the newspapers top reporters tell each one with perceptiveness and skill.